Subscribe to RSS
DOI: 10.1055/s-0031-1289607
Novel σ1 Receptor Ligands by Oxa-Pictet-Spengler Reaction of Pyrazolylethanol
Publication History
Publication Date:
15 November 2011 (online)

Abstract
The oxa-Pictet-Spengler reaction of 2-(1-phenylpyrazol-5-yl)ethanol required the weak acid pyridinium p-toluenesulfonate to provide pyrano[4,3-c]pyrazoles with additional functional groups in the side chain. These functional groups allow the introduction of various amino substituents into the side chain in position 4. In receptor binding studies the aminoethyl-substituted pyranopyrazoles revealed higher σ1 receptor affinities and σ1/σ2 selectivities than the shorter aminomethyl homologues. The pyranopyrazole bearing the phenylpiperidine substituent (K i = 0.99 nM) represents the most potent and that bearing the piperidine substituent the most selective (σ1/σ2 = 180) σ1 ligands of this series of compounds.
Keywords
σ1 receptor ligands - oxa-Pictet-Spengler reaction - annulated pyrazoles - pyrazolylethanol - structure affinity relationships
- 1
Kitaichi K.Chabot JG.Moebius FF.Flandorfer A.Glossmann H.Quirion R. J. Chem. Neuroanat. 2000, 20: 375Reference Ris Wihthout Link - 2
Alonso G.Phan V.Guillemain I.Saunier M.Legrand A.Anoal M.Maurice T. Neuroscience 2000, 97: 155Reference Ris Wihthout Link - 3
Hayashi T.Su TP. CNS Drugs 2004, 18: 269Reference Ris Wihthout Link - 4
Cobos EJ.Entrena JM.Nieto FR.Cendan CM.DelPezo E. Curr. Pharmacol. 2008, 6: 344Reference Ris Wihthout Link - 5
Maurice T.Su TP. Pharmacol. Ther. 2009, 124: 195Reference Ris Wihthout Link - 6
Ishikawa M.Hashimoto K. J. Receptor Ligand Channel Res. 2010, 3: 25Reference Ris Wihthout Link - 7
Mach RH.Wheeler KT. Cent. Nerv. Syst. Agents Med. Chem. 2009, 9: 230Reference Ris Wihthout Link - 8
Diaz JL.Zamanillo D.Corbera J.Baeyens JM.Maldonado R.Pericas MA.Vela JM.Torrens A. Cent. Nerv. Syst. Agents Med. Chem. 2009, 9: 172Reference Ris Wihthout Link - 9
Corbera AJ.Vaño D.Martínez D.Vela JM.Zamanillo D.Dordal A.Andreu F.Hernandez E.Perez R.Escriche M.Salgado L.Yeste S.Serafini MT.Pascual R.Alegre J.Calvet MC.Cano N.Carro M.Buschmann H.Holenz J. ChemMedChem 2006, 1: 140Reference Ris Wihthout Link - 10
Entrena JM.Cobos EJ.Nieto FR.Cendan CM.Gris G.Del Pozo E.Zampanillo D.Baeyens JM. Pain 2009, 143: 252Reference Ris Wihthout Link - 11
Corbera AJ,Cuberes-Altisent MR,Holenz J,Martinez-Olmo D, andVano-Domenech D. inventors; WO 2006,021,463.Reference Ris Wihthout Link - 12
Schläger T.Schepmann D.Lehmkuhl K.Holenz J.Vela JM.Buschmann H.Wünsch B. J. Med. Chem. 2011, 54: 6704Reference Ris Wihthout Link - 13
Wünsch B.Zott M. Liebigs Ann. Chem. 1992, 39Reference Ris Wihthout Link - 14
Larghi EL.Kaufman TS. Synthesis 2006, 187Reference Ris Wihthout Link - 15
Larghi EL.Kaufman TS. Eur. J. Org. Chem. 2011, 5195Reference Ris Wihthout Link - 16
Bouguerne B.Lherbet C.Baltas M. Lett. Org. Chem. 2010, 7: 420Reference Ris Wihthout Link - 17
Bouguerne B.Hoffmann P.Lherbet C. Synth. Commun. 2010, 40: 915Reference Ris Wihthout Link - 18
Schläger T.Oberdorf C.Tewes B.Wünsch B. Synthesis 2008, 1793Reference Ris Wihthout Link - 19
Schomaker JM.Pulgam VR.Borhan B. J. Am. Chem. Soc. 2004, 126: 13600Reference Ris Wihthout Link - 20
Dess DB.Martin JC. J. Org. Chem. 1983, 48: 4155Reference Ris Wihthout Link - 21
Abdel-Magid AF.Mehrmann SJ. Org. Process Res. Dev. 2006, 10: 971Reference Ris Wihthout Link - 22
Maier CA.Wünsch B. J. Med. Chem. 2002, 45: 438Reference Ris Wihthout Link - 23
Große Maestrup E.Wiese C.Schepmann D.Hiller A.Fischer S.Scheunemann M.Brust P.Wünsch B. Bioorg. Med. Chem. 2009, 17: 3630Reference Ris Wihthout Link - 24
Holl R.Schepmann D.Fröhlich R.Grünert R.Bednarski PJ.Wünsch B. J. Med. Chem. 2009, 52: 2126Reference Ris Wihthout Link